Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-21-014425
Filing Date
2021-06-09
Accepted
2021-06-09 16:20:40
Documents
1
Period of Report
2021-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3775
  Complete submission text file 0001437749-21-014425.txt   5400
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Celsion CORP (Issuer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10 FINDERNE AVENUE BRIDGEWATER NJ 08807
Business Address
Pellizzari Christine A (Reporting) CIK: 0001127430 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15911 | Film No.: 211005345